GLENZA (Enzalutamide) is a non-steroidal anti-androgen drug (NSAA), works by blocking the effect of the natural male hormones on the growth of prostate cells.
It is used to treat adult men with prostate cancer that no longer responds to androgen deprivation therapy.
A proton pump inhibitor, it is also used in the treatment of stomach ulcers, gastroesophageal reflux disease (GERD) and other acidity related disorders. This medicine works by interfering with the final step of acid release in the stomach. Thus, acidity in the stomach is decreased.